UNSPSC 51333402: Batoprazine

This classification denotes an antipsychotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EZY3PL8Q0M. European Medicines Agency schedules Batoprazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05670MIG. Batoprazine generally arises in the molecular formula C13H14N2O2.

UNSPSC 51333402 Batoprazine (Commodity) does not reflect the work state and local governments are actually soliciting under this code. The single recent opportunity tagged to this code — a Seminole County, Florida procurement — seeks naloxone and safe drug deactivation systems for community health initiatives, neither of which aligns with batoprazine, a proton pump inhibitor medication used to treat gastric acid disorders. The mismatch suggests either a tagging error in the source data or that this Commodity code sees minimal, misaligned recent activity in state and local procurement.

No additional opportunities supporting this code's nominal scope appear in the available records. Without representative state and local solicitations for batoprazine itself, geographic concentration, issuing-body patterns, or response timeline signals cannot be established from current activity.